Invention Grant
US08735399B2 Selective subtype alpha 2 adrenergic agents and methods for use thereof
有权
选择性亚型α2肾上腺素能药物及其使用方法
- Patent Title: Selective subtype alpha 2 adrenergic agents and methods for use thereof
- Patent Title (中): 选择性亚型α2肾上腺素能药物及其使用方法
-
Application No.: US12863386Application Date: 2009-01-14
-
Publication No.: US08735399B2Publication Date: 2014-05-27
- Inventor: Todd M. Heidelbaugh , Ken Chow , Santosh C. Sinha , Phong X. Nguyen , Wenkui K. Fang , Ling Li , Janet A. Takeuchi , Smita S. Bhat
- Applicant: Todd M. Heidelbaugh , Ken Chow , Santosh C. Sinha , Phong X. Nguyen , Wenkui K. Fang , Ling Li , Janet A. Takeuchi , Smita S. Bhat
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Doina G. Ene
- International Application: PCT/US2009/030887 WO 20090114
- International Announcement: WO2009/091760 WO 20090723
- Main IPC: A61K31/422
- IPC: A61K31/422 ; A61K31/497 ; C07D241/12 ; C07D263/12 ; C07D413/12 ; C07D213/18
Abstract:
The invention provides oxazolidine and thiazolidine derivatives that are useful as subtype selective alpha 2 adrenergic agonists. As such, the compounds described herein are useful in treating a wide variety of disorders associated with selective subtype modulation of alpha 2 adrenergic receptors.
Public/Granted literature
- US20110105526A1 SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF Public/Granted day:2011-05-05
Information query
IPC分类:
